Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 31

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
 the expected remaining life of the option. The expected life of the option is assumed to be equivalent
to their remaining contractual term.

The rights were valued using an iterative analysis
based on market comparable. The following criteria was utilized to select comparable Special Purpose Acquisition Companies who were pre-business
combination and included rights as part of their units that were publicly trading with significant time remaining to complete their initial
business combination:

    Criteria 
    Low  
    High 
  
    IPO Proceeds 
     60  
     250 
  
    Warrant Coverage 
     -  
     0.5 
  
    Rights Coverage (per unit) 
     0.05  
     0.13 
  
    Remaining Months to Complete 
     7  
     21 

17

DRUGS MADE IN AMERICA ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

JUNE 30, 2025

(Unaudited)

NOTE 9 — SEGMENT INFORMATION

ASC Topic 280, “Segment Reporting,”
establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic
areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information
is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding
how to allocate resources and assess performance.

The Company’s CODM has been identified as
the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources
and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

The CODM assesses performance for the single segment
and decides how to allocate resources based on net income or loss that also is reported on the unaudited statement of operations as net
income or loss. The measure of segment assets is reported on the unaudited balance sheets as total assets. When evaluating the Company’s
performance and making key decisions regarding resource allocation, the CODM reviews key metrics, which includes general and administrative
expenses and interest earned on cash and investments held in Trust Account which are included in the accompanying unaudited statements
of operations.

The key metrics included in segment profit or
loss reviewed by the CODM are interest earned on cash and investments held in Trust Account and general and administrative costs. The
CODM reviews interest earned on cash and investments held in the Trust Account to measure